Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Earnings
Nuance sees Q4 adjusted EPS 13c-18c, consensus 20c » 17:48
08/05/20
08/05
17:48
08/05/20
17:48
NUAN

Nuance

$28.65 /

+0.36 (+1.27%)

Sees Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NUAN Nuance
$28.65 /

+0.36 (+1.27%)

NUAN Nuance
$28.65 /

+0.36 (+1.27%)

07/16/20 Morgan Stanley
Nuance price target raised to $30 from $20 at Morgan Stanley
06/29/20 SVB Leerink
SVB Leerink bullish on Nuance, initiates with an Outperform
06/29/20 SVB Leerink
Nuance initiated with an Outperform at SVB Leerink
04/14/20 Spin-Off Research
Nuance upgraded to Buy from Hold at Spin-Off Research
NUAN Nuance
$28.65 /

+0.36 (+1.27%)

Earnings
Nuance narrows FY20 EPS view to 78c-83c from 76c-86c, consensus 80c » 17:08
08/05/20
08/05
17:08
08/05/20
17:08
NUAN

Nuance

$28.65 /

+0.36 (+1.27%)

Narrows FY20 revenue view…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NUAN Nuance
$28.65 /

+0.36 (+1.27%)

NUAN Nuance
$28.65 /

+0.36 (+1.27%)

07/16/20 Morgan Stanley
Nuance price target raised to $30 from $20 at Morgan Stanley
06/29/20 SVB Leerink
SVB Leerink bullish on Nuance, initiates with an Outperform
06/29/20 SVB Leerink
Nuance initiated with an Outperform at SVB Leerink
04/14/20 Spin-Off Research
Nuance upgraded to Buy from Hold at Spin-Off Research
NUAN Nuance
$28.65 /

+0.36 (+1.27%)

Earnings
Nuance reports Q3 non-GAAP EPS 18c, consensus 12c » 16:03
08/05/20
08/05
16:03
08/05/20
16:03
NUAN

Nuance

$28.47 /

+0.18 (+0.64%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NUAN Nuance
$28.47 /

+0.18 (+0.64%)

NUAN Nuance
$28.47 /

+0.18 (+0.64%)

07/16/20 Morgan Stanley
Nuance price target raised to $30 from $20 at Morgan Stanley
06/29/20 SVB Leerink
SVB Leerink bullish on Nuance, initiates with an Outperform
06/29/20 SVB Leerink
Nuance initiated with an Outperform at SVB Leerink
04/14/20 Spin-Off Research
Nuance upgraded to Buy from Hold at Spin-Off Research
NUAN Nuance
$28.47 /

+0.18 (+0.64%)

Thursday
Hot Stocks
Nuance expands AI collaboration with Cerner » 07:18
07/30/20
07/30
07:18
07/30/20
07:18
NUAN

Nuance

$27.57 /

+0.855 (+3.20%)

, CERN

Cerner

$73.40 /

+2.24 (+3.15%)

Nuance Communications …

Nuance Communications (NUAN) announced that it has expanded its long-standing AI collaboration with Cerner (CERN) to include the integration of Nuance's virtual assistant technology into the Cerner Millennium electronic health record. Building upon the existing integration between Nuance's Dragon Medical platform and Cerner Millennium, joint clients can utilize Nuance's advanced natural language virtual assistant technology to navigate the EHR using just their voice, giving clinicians more time to spend with their patients and less time with their computer. Select joint Cerner and Nuance clients can expect to start deploying this integrated virtual assistant technology later this year.

ShowHide Related Items >><<
NUAN Nuance
$27.57 /

+0.855 (+3.20%)

CERN Cerner
$73.40 /

+2.24 (+3.15%)

NUAN Nuance
$27.57 /

+0.855 (+3.20%)

07/16/20 Morgan Stanley
Nuance price target raised to $30 from $20 at Morgan Stanley
06/29/20 SVB Leerink
SVB Leerink bullish on Nuance, initiates with an Outperform
06/29/20 SVB Leerink
Nuance initiated with an Outperform at SVB Leerink
04/14/20 Spin-Off Research
Nuance upgraded to Buy from Hold at Spin-Off Research
CERN Cerner
$73.40 /

+2.24 (+3.15%)

07/06/20 Stephens
Cerner initiated with an Equal Weight at Stephens
06/15/20 Evercore ISI
Cerner assumed with an In Line at Evercore ISI
06/10/20 Lake Street
OptimizeRx news strategically significant, broadens reach, says Lake Street
06/09/20 Piper Sandler
GAO reports validate Cerner contract with VA, says Piper Sandler
NUAN Nuance
$27.57 /

+0.855 (+3.20%)

CERN Cerner
$73.40 /

+2.24 (+3.15%)

CERN Cerner
$73.40 /

+2.24 (+3.15%)

CERN Cerner
$73.40 /

+2.24 (+3.15%)

CERN Cerner
$73.40 /

+2.24 (+3.15%)

Over a week ago
Recommendations
Nuance price target raised to $30 from $20 at Morgan Stanley » 08:00
07/16/20
07/16
08:00
07/16/20
08:00
NUAN

Nuance

$25.35 /

+0.49 (+1.97%)

Morgan Stanley analyst…

Morgan Stanley analyst Sanjit Singh raised the firm's price target on Nuance to $30 from $20 and keeps an Overweight rating on the shares. Recent interviews with hospital CIOs and physicians substantiate the efficiency gains enabled by the company's Dragon Ambient Experience, or DAX, and leave Singh more optimistic that adoption will accelerate once the pandemic crisis subsides, the analyst tells investors. While continuing to assume no DAX contribution in FY20, Singh revised base case now formally includes DAX starts contributing to revenue in FY21, the analyst noted.

ShowHide Related Items >><<
NUAN Nuance
$25.35 /

+0.49 (+1.97%)

NUAN Nuance
$25.35 /

+0.49 (+1.97%)

06/29/20 SVB Leerink
SVB Leerink bullish on Nuance, initiates with an Outperform
06/29/20 SVB Leerink
Nuance initiated with an Outperform at SVB Leerink
04/14/20 Spin-Off Research
Nuance upgraded to Buy from Hold at Spin-Off Research
04/14/20 Guggenheim
Guggenheim starts Nuance at Neutral amid potential delays in hospital buying
NUAN Nuance
$25.35 /

+0.49 (+1.97%)

Over a month ago
Initiation
SVB Leerink bullish on Nuance, initiates with an Outperform » 08:31
06/29/20
06/29
08:31
06/29/20
08:31
NUAN

Nuance

$25.39 /

+0.55 (+2.21%)

As previously reported,…

As previously reported, SVB Leerink analyst Stephanie Davis initiated coverage of Nuance with an Outperform rating and $31 price target. With consumer virtual assistant/AI solutions reaching mainstream status, the analyst believes Nuance is well positioned to ride this wave and introduce conversational AI technology in a more meaningful way to its end markets, fueling a multi-year growth and margin expansion story.

ShowHide Related Items >><<
NUAN Nuance
$25.39 /

+0.55 (+2.21%)

NUAN Nuance
$25.39 /

+0.55 (+2.21%)

06/29/20 SVB Leerink
Nuance initiated with an Outperform at SVB Leerink
04/14/20 Spin-Off Research
Nuance upgraded to Buy from Hold at Spin-Off Research
04/14/20 Guggenheim
Guggenheim starts Nuance at Neutral amid potential delays in hospital buying
04/14/20 Guggenheim
Nuance initiated with a Neutral at Guggenheim
NUAN Nuance
$25.39 /

+0.55 (+2.21%)

Initiation
Nuance initiated with an Outperform at SVB Leerink » 06:18
06/29/20
06/29
06:18
06/29/20
06:18
NUAN

Nuance

$25.39 /

+0.55 (+2.21%)

SVB Leerink analyst…

SVB Leerink analyst Stephanie Davis initiated coverage of Nuance with an Outperform rating and $31 price target.

ShowHide Related Items >><<
NUAN Nuance
$25.39 /

+0.55 (+2.21%)

NUAN Nuance
$25.39 /

+0.55 (+2.21%)

04/14/20 Spin-Off Research
Nuance upgraded to Buy from Hold at Spin-Off Research
04/14/20 Guggenheim
Guggenheim starts Nuance at Neutral amid potential delays in hospital buying
04/14/20 Guggenheim
Nuance initiated with a Neutral at Guggenheim
03/12/20 Wedbush
Apple, Microsoft among tech names to own through COVID-19 slowdown, says Wedbush
NUAN Nuance
$25.39 /

+0.55 (+2.21%)

Earnings
Nuance sees Q3 adjusted EPS 10c-14c, consensus 18c » 17:35
05/07/20
05/07
17:35
05/07/20
17:35
NUAN

Nuance

$20.24 /

+0.865 (+4.46%)

Sees Q3 revenue…

Sees Q3 revenue $302M-$328M, consensus $353.15M. Guidance taken from Q2 earnings conference call.

ShowHide Related Items >><<
NUAN Nuance
$20.24 /

+0.865 (+4.46%)

04/14/20 Spin-Off Research
Nuance upgraded to Buy from Hold at Spin-Off Research
04/14/20 Guggenheim
Guggenheim starts Nuance at Neutral amid potential delays in hospital buying
04/14/20 Guggenheim
Nuance initiated with a Neutral at Guggenheim
03/12/20 Wedbush
Apple, Microsoft among tech names to own through COVID-19 slowdown, says Wedbush
Earnings
Nuance lowers FY20 non-GAAP EPS view to 76c-86c from 82c-90c, consensus 92c » 16:32
05/07/20
05/07
16:32
05/07/20
16:32
NUAN

Nuance

$20.24 /

+0.865 (+4.46%)

Lowers FY20 revenue view…

Lowers FY20 revenue view to $1.41B-$1.49B from $1.5B-$1.54B, consensus $1.48B.

ShowHide Related Items >><<
NUAN Nuance
$20.24 /

+0.865 (+4.46%)

04/14/20 Spin-Off Research
Nuance upgraded to Buy from Hold at Spin-Off Research
04/14/20 Guggenheim
Guggenheim starts Nuance at Neutral amid potential delays in hospital buying
04/14/20 Guggenheim
Nuance initiated with a Neutral at Guggenheim
03/12/20 Wedbush
Apple, Microsoft among tech names to own through COVID-19 slowdown, says Wedbush
Earnings
Nuance reports Q2 non-GAAP EPS (21c), consensus (17c) » 16:25
05/07/20
05/07
16:25
05/07/20
16:25
NUAN

Nuance

$20.24 /

+0.865 (+4.46%)

Reports Q2 revenue…

Reports Q2 revenue $369.3M, consensus $352.99M. "Despite COVID-19, we had another excellent quarter, with revenue and EPS exceeding the high end of our guidance," said CEO Mark Benjamin. "We achieved 11% year-over-year organic revenue growth, with strength from both our Healthcare and Enterprise segments. Enterprise reported 19% annual revenue growth, the highest in 10 years, driven by our Intelligent Engagement solutions. Healthcare revenue grew 10% year-over-year, driven by strong growth in Dragon Medical cloud and increased demand from our newer cloud-based solutions, PowerScribe One and CDE One".

ShowHide Related Items >><<
NUAN Nuance
$20.24 /

+0.865 (+4.46%)

04/14/20 Spin-Off Research
Nuance upgraded to Buy from Hold at Spin-Off Research
04/14/20 Guggenheim
Guggenheim starts Nuance at Neutral amid potential delays in hospital buying
04/14/20 Guggenheim
Nuance initiated with a Neutral at Guggenheim
03/12/20 Wedbush
Apple, Microsoft among tech names to own through COVID-19 slowdown, says Wedbush

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.